Advertisement

Topics

Public offering nets $164.5mm for Endocyte

15:40 EDT 13 Sep 2018 | Elsevier Business Intelligence

Endocyte Inc. (targeted cancer therapies and companion imaging agents) netted $164.5mm through the public sale of 9.5mm commo...

Original Article: Public offering nets $164.5mm for Endocyte

NEXT ARTICLE

More From BioPortfolio on "Public offering nets $164.5mm for Endocyte"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...